+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bone Grafts and Substitutes Market 2023-2027

  • PDF Icon

    Report

  • 173 Pages
  • February 2023
  • Region: Global
  • TechNavio
  • ID: 5583788
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bone grafts and substitutes market is forecasted to grow by $1450.51 mn during 2022-2027, accelerating at a CAGR of 8.71% during the forecast period. The report on the bone grafts and substitutes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing number of orthopedic conditions and surgical cases, increasing demand for dental bone grafts, and rising investment in clinical trials.

The bone grafts and substitutes market is segmented as below:

By Product

  • Xenografts
  • Allografts
  • Synthetic bone grafts
  • DBM

By Application

  • Spinal fusion
  • Trauma
  • Craniomaxillofacial
  • Joint reconstruction
  • Dental bone grafting

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing adoption of minimally invasive surgeries as one of the prime reasons driving the bone grafts and substitutes market growth during the next few years. Also, emergence of 3D printing in bone grafting and increasing dental tourism in developing countries will lead to sizable demand in the market.

The report on the bone grafts and substitutes market covers the following areas:

  • Bone grafts and substitutes market sizing
  • Bone grafts and substitutes market forecast
  • Bone grafts and substitutes market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bone grafts and substitutes market vendors that include AlloSource, Arthrex Inc., Baxter International Inc., Bioventus LLC, Geistlich Pharma AG, Integra Lifesciences Holdings Corp., Johnson and Johnson, Medtronic Plc, MTF Biologics, NovaBone Products LLC, Nuvasive Inc., Orthofix Medical Inc., OST Laboratories, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., TBF TISSUE ENGINEERING, Xtant Medical Inc., and Zimmer Biomet Holdings Inc. Also, the bone grafts and substitutes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global bone grafts and substitutes market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global bone grafts and substitutes market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Xenografts - Market size and forecast 2022-2027
Exhibit 34: Chart on Xenografts - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Xenografts - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Xenografts - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Xenografts - Year-over-year growth 2022-2027 (%)
6.4 Allografts - Market size and forecast 2022-2027
Exhibit 38: Chart on Allografts - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Allografts - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Allografts - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Allografts - Year-over-year growth 2022-2027 (%)
6.5 Synthetic bone grafts - Market size and forecast 2022-2027
Exhibit 42: Chart on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Synthetic bone grafts - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Synthetic bone grafts - Year-over-year growth 2022-2027 (%)
6.6 DBM - Market size and forecast 2022-2027
Exhibit 46: Chart on DBM - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on DBM - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on DBM - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on DBM - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Product
Exhibit 50: Market opportunity by Product ($ million)
Exhibit 51: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 52: Chart on Application - Market share 2022-2027 (%)
Exhibit 53: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 54: Chart on Comparison by Application
Exhibit 55: Data Table on Comparison by Application
7.3 Spinal fusion - Market size and forecast 2022-2027
Exhibit 56: Chart on Spinal fusion - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Spinal fusion - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Spinal fusion - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Spinal fusion - Year-over-year growth 2022-2027 (%)
7.4 Trauma - Market size and forecast 2022-2027
Exhibit 60: Chart on Trauma - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Trauma - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Trauma - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Trauma - Year-over-year growth 2022-2027 (%)
7.5 Craniomaxillofacial - Market size and forecast 2022-2027
Exhibit 64: Chart on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Craniomaxillofacial - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Craniomaxillofacial - Year-over-year growth 2022-2027 (%)
7.6 Joint reconstruction - Market size and forecast 2022-2027
Exhibit 68: Chart on Joint reconstruction - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Data Table on Joint reconstruction - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Chart on Joint reconstruction - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Joint reconstruction - Year-over-year growth 2022-2027 (%)
7.7 Dental bone grafting - Market size and forecast 2022-2027
Exhibit 72: Chart on Dental bone grafting - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Data Table on Dental bone grafting - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Chart on Dental bone grafting - Year-over-year growth 2022-2027 (%)
Exhibit 75: Data Table on Dental bone grafting - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Application
Exhibit 76: Market opportunity by Application ($ million)
Exhibit 77: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 79: Chart on Market share by geography 2022-2027 (%)
Exhibit 80: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 81: Chart on Geographic comparison
Exhibit 82: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 107: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 115: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 116: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 119: Market opportunity by geography ($ million)
Exhibit 120: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 121: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 123: Overview on factors of disruption
11.4 Industry risks
Exhibit 124: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 125: Vendors covered
12.2 Market positioning of vendors
Exhibit 126: Matrix on vendor position and classification
12.3 AlloSource
Exhibit 127: AlloSource - Overview
Exhibit 128: AlloSource - Product/Service
Exhibit 129: AlloSource - Key offerings
12.4 Arthrex Inc.
Exhibit 130: Arthrex Inc. - Overview
Exhibit 131: Arthrex Inc. - Product/Service
Exhibit 132: Arthrex Inc. - Key offerings
12.5 Baxter International Inc.
Exhibit 133: Baxter International Inc. - Overview
Exhibit 134: Baxter International Inc. - Business segments
Exhibit 135: Baxter International Inc. - Key news
Exhibit 136: Baxter International Inc. - Key offerings
Exhibit 137: Baxter International Inc. - Segment focus
12.6 Bioventus LLC
Exhibit 138: Bioventus LLC - Overview
Exhibit 139: Bioventus LLC - Business segments
Exhibit 140: Bioventus LLC - Key news
Exhibit 141: Bioventus LLC - Key offerings
Exhibit 142: Bioventus LLC - Segment focus
12.7 Geistlich Pharma AG
Exhibit 143: Geistlich Pharma AG - Overview
Exhibit 144: Geistlich Pharma AG - Product/Service
Exhibit 145: Geistlich Pharma AG - Key offerings
12.8 Integra Lifesciences Holdings Corp.
Exhibit 146: Integra Lifesciences Holdings Corp. - Overview
Exhibit 147: Integra Lifesciences Holdings Corp. - Business segments
Exhibit 148: Integra Lifesciences Holdings Corp. - Key news
Exhibit 149: Integra Lifesciences Holdings Corp. - Key offerings
Exhibit 150: Integra Lifesciences Holdings Corp. - Segment focus
12.9 Johnson and Johnson
Exhibit 151: Johnson and Johnson - Overview
Exhibit 152: Johnson and Johnson - Business segments
Exhibit 153: Johnson and Johnson - Key news
Exhibit 154: Johnson and Johnson - Key offerings
Exhibit 155: Johnson and Johnson - Segment focus
12.10 Medtronic Plc
Exhibit 156: Medtronic Plc - Overview
Exhibit 157: Medtronic Plc - Business segments
Exhibit 158: Medtronic Plc - Key news
Exhibit 159: Medtronic Plc - Key offerings
Exhibit 160: Medtronic Plc - Segment focus
12.11 MTF Biologics
Exhibit 161: MTF Biologics - Overview
Exhibit 162: MTF Biologics - Product/Service
Exhibit 163: MTF Biologics - Key offerings
12.12 NovaBone Products LLC
Exhibit 164: NovaBone Products LLC - Overview
Exhibit 165: NovaBone Products LLC - Product/Service
Exhibit 166: NovaBone Products LLC - Key offerings
12.13 Nuvasive Inc.
Exhibit 167: Nuvasive Inc. - Overview
Exhibit 168: Nuvasive Inc. - Business segments
Exhibit 169: Nuvasive Inc. - Key news
Exhibit 170: Nuvasive Inc. - Key offerings
Exhibit 171: Nuvasive Inc. - Segment focus
12.14 Orthofix Medical Inc.
Exhibit 172: Orthofix Medical Inc. - Overview
Exhibit 173: Orthofix Medical Inc. - Business segments
Exhibit 174: Orthofix Medical Inc. - Key news
Exhibit 175: Orthofix Medical Inc. - Key offerings
Exhibit 176: Orthofix Medical Inc. - Segment focus
12.15 OST Laboratories
Exhibit 177: OST Laboratories - Overview
Exhibit 178: OST Laboratories - Product/Service
Exhibit 179: OST Laboratories - Key offerings
12.16 Smith and Nephew plc
Exhibit 180: Smith and Nephew plc - Overview
Exhibit 181: Smith and Nephew plc - Business segments
Exhibit 182: Smith and Nephew plc - Key news
Exhibit 183: Smith and Nephew plc - Key offerings
Exhibit 184: Smith and Nephew plc - Segment focus
12.17 Stryker Corp.
Exhibit 185: Stryker Corp. - Overview
Exhibit 186: Stryker Corp. - Business segments
Exhibit 187: Stryker Corp. - Key news
Exhibit 188: Stryker Corp. - Key offerings
Exhibit 189: Stryker Corp. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 190: Inclusions checklist
Exhibit 191: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 192: Currency conversion rates for US$
13.4 Research methodology
Exhibit 193: Research methodology
Exhibit 194: Validation techniques employed for market sizing
Exhibit 195: Information sources
13.5 List of abbreviations
Exhibit 196: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global bone grafts and substitutes market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Xenografts - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Xenografts - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Xenografts - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Xenografts - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Allografts - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Allografts - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Allografts - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Allografts - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Synthetic bone grafts - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Synthetic bone grafts - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on DBM - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on DBM - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on DBM - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on DBM - Year-over-year growth 2022-2027 (%)
Exhibits 50: Market opportunity by Product ($ million)
Exhibits 51: Data Table on Market opportunity by Product ($ million)
Exhibits 52: Chart on Application - Market share 2022-2027 (%)
Exhibits 53: Data Table on Application - Market share 2022-2027 (%)
Exhibits 54: Chart on Comparison by Application
Exhibits 55: Data Table on Comparison by Application
Exhibits 56: Chart on Spinal fusion - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Spinal fusion - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Spinal fusion - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Spinal fusion - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Trauma - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Trauma - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Trauma - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Trauma - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Data Table on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Chart on Craniomaxillofacial - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Craniomaxillofacial - Year-over-year growth 2022-2027 (%)
Exhibits 68: Chart on Joint reconstruction - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Data Table on Joint reconstruction - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Chart on Joint reconstruction - Year-over-year growth 2022-2027 (%)
Exhibits 71: Data Table on Joint reconstruction - Year-over-year growth 2022-2027 (%)
Exhibits 72: Chart on Dental bone grafting - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Data Table on Dental bone grafting - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Chart on Dental bone grafting - Year-over-year growth 2022-2027 (%)
Exhibits 75: Data Table on Dental bone grafting - Year-over-year growth 2022-2027 (%)
Exhibits 76: Market opportunity by Application ($ million)
Exhibits 77: Data Table on Market opportunity by Application ($ million)
Exhibits 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 79: Chart on Market share by geography 2022-2027 (%)
Exhibits 80: Data Table on Market share by geography 2022-2027 (%)
Exhibits 81: Chart on Geographic comparison
Exhibits 82: Data Table on Geographic comparison
Exhibits 83: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 108: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 109: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 111: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 112: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 114: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 115: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 116: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 119: Market opportunity by geography ($ million)
Exhibits 120: Data Tables on Market opportunity by geography ($ million)
Exhibits 121: Impact of drivers and challenges in 2022 and 2027
Exhibits 122: Overview on Criticality of inputs and Factors of differentiation
Exhibits 123: Overview on factors of disruption
Exhibits 124: Impact of key risks on business
Exhibits 125: Vendors covered
Exhibits 126: Matrix on vendor position and classification
Exhibits 127: AlloSource - Overview
Exhibits 128: AlloSource - Product/Service
Exhibits 129: AlloSource - Key offerings
Exhibits 130: Arthrex Inc. - Overview
Exhibits 131: Arthrex Inc. - Product/Service
Exhibits 132: Arthrex Inc. - Key offerings
Exhibits 133: Baxter International Inc. - Overview
Exhibits 134: Baxter International Inc. - Business segments
Exhibits 135: Baxter International Inc. - Key news
Exhibits 136: Baxter International Inc. - Key offerings
Exhibits 137: Baxter International Inc. - Segment focus
Exhibits 138: Bioventus LLC - Overview
Exhibits 139: Bioventus LLC - Business segments
Exhibits 140: Bioventus LLC - Key news
Exhibits 141: Bioventus LLC - Key offerings
Exhibits 142: Bioventus LLC - Segment focus
Exhibits 143: Geistlich Pharma AG - Overview
Exhibits 144: Geistlich Pharma AG - Product/Service
Exhibits 145: Geistlich Pharma AG - Key offerings
Exhibits 146: Integra Lifesciences Holdings Corp. - Overview
Exhibits 147: Integra Lifesciences Holdings Corp. - Business segments
Exhibits 148: Integra Lifesciences Holdings Corp. - Key news
Exhibits 149: Integra Lifesciences Holdings Corp. - Key offerings
Exhibits 150: Integra Lifesciences Holdings Corp. - Segment focus
Exhibits 151: Johnson and Johnson - Overview
Exhibits 152: Johnson and Johnson - Business segments
Exhibits 153: Johnson and Johnson - Key news
Exhibits 154: Johnson and Johnson - Key offerings
Exhibits 155: Johnson and Johnson - Segment focus
Exhibits 156: Medtronic Plc - Overview
Exhibits 157: Medtronic Plc - Business segments
Exhibits 158: Medtronic Plc - Key news
Exhibits 159: Medtronic Plc - Key offerings
Exhibits 160: Medtronic Plc - Segment focus
Exhibits 161: MTF Biologics - Overview
Exhibits 162: MTF Biologics - Product/Service
Exhibits 163: MTF Biologics - Key offerings
Exhibits 164: NovaBone Products LLC - Overview
Exhibits 165: NovaBone Products LLC - Product/Service
Exhibits 166: NovaBone Products LLC - Key offerings
Exhibits 167: Nuvasive Inc. - Overview
Exhibits 168: Nuvasive Inc. - Business segments
Exhibits 169: Nuvasive Inc. - Key news
Exhibits 170: Nuvasive Inc. - Key offerings
Exhibits 171: Nuvasive Inc. - Segment focus
Exhibits 172: Orthofix Medical Inc. - Overview
Exhibits 173: Orthofix Medical Inc. - Business segments
Exhibits 174: Orthofix Medical Inc. - Key news
Exhibits 175: Orthofix Medical Inc. - Key offerings
Exhibits 176: Orthofix Medical Inc. - Segment focus
Exhibits 177: OST Laboratories - Overview
Exhibits 178: OST Laboratories - Product/Service
Exhibits 179: OST Laboratories - Key offerings
Exhibits 180: Smith and Nephew plc - Overview
Exhibits 181: Smith and Nephew plc - Business segments
Exhibits 182: Smith and Nephew plc - Key news
Exhibits 183: Smith and Nephew plc - Key offerings
Exhibits 184: Smith and Nephew plc - Segment focus
Exhibits 185: Stryker Corp. - Overview
Exhibits 186: Stryker Corp. - Business segments
Exhibits 187: Stryker Corp. - Key news
Exhibits 188: Stryker Corp. - Key offerings
Exhibits 189: Stryker Corp. - Segment focus
Exhibits 190: Inclusions checklist
Exhibits 191: Exclusions checklist
Exhibits 192: Currency conversion rates for US$
Exhibits 193: Research methodology
Exhibits 194: Validation techniques employed for market sizing
Exhibits 195: Information sources
Exhibits 196: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global bone grafts and substitutes market: AlloSource, Arthrex Inc., Baxter International Inc., Bioventus LLC, Geistlich Pharma AG, Integra Lifesciences Holdings Corp., Johnson and Johnson, Medtronic Plc, MTF Biologics, NovaBone Products LLC, Nuvasive Inc., Orthofix Medical Inc., OST Laboratories, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., TBF TISSUE ENGINEERING, Xtant Medical Inc., and Zimmer Biomet Holdings Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing adoption of minimally invasive surgeries.'

According to the report, one of the major drivers for this market is the growing number of orthopedic conditions and surgical cases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AlloSource
  • Arthrex Inc.
  • Baxter International Inc.
  • Bioventus LLC
  • Geistlich Pharma AG
  • Integra Lifesciences Holdings Corp.
  • Johnson and Johnson
  • Medtronic Plc
  • MTF Biologics
  • NovaBone Products LLC
  • Nuvasive Inc.
  • Orthofix Medical Inc.
  • OST Laboratories
  • RTI Surgical Inc.
  • SeaSpine Holdings Corp.
  • Smith and Nephew plc
  • Stryker Corp.
  • TBF TISSUE ENGINEERING
  • Xtant Medical Inc.
  • Zimmer Biomet Holdings Inc.